Multiple myeloma, stage 3, diagnosed in [**2142**] with dentistry radiographs, treated with Melphalan and prednisone with minimal response, status post Vincristine, Doxorubicin, and Dexamethasone, status post ablative bone marrow transplant in [**2143-3-25**], status post nonablative allogeneic bone marrow transplant in [**2143-11-25**].
Skin and subcutaneous skin necrosis secondary to VAD extravasation.
PAST SURGICAL HISTORY:  The patient had tonsillectomy as a child.
Beta microglobulin pending.
ADMITTING MEDICATIONS:  Verapamil 180 mg po q day.
No evidence of airway compromise was noted, but because of the inflammation in the area, the Ear, Nose, and Throat service recommended close monitoring in an Intensive Care Unit for continuous O2 saturation monitoring.
The patient was begun on Decadron 10 mg IV q six hours as well as empiric antibiotics therapy with IV Unasyn.
The patient experienced considerable clinical improvement with IV steroids and IV antibiotics.
The patient's Decadron was discontinued in the Intensive Care Unit.
After approximately 48 hours of IV Unasyn, the patient was changed to po Augmentin and recommended to complete a ten day course of po Augmentin by the Ear, Nose, and Throat service.
Pulmonary:  The patient required no supplemental oxygen throughout her stay in the Medical Intensive Care Unit.
BMT DISCHARGE MEDICATIONS:  Verapamil 180 mg po q day and Augmentin 875 mg po bid times ten days.
